Transcriptional Dysregulation Study Reveals a Core Network Involving the Progression of Alzheimer's Disease

Background The pathogenesis of Alzheimer’s disease is associated with dysregulation at different levels from transcriptome to cellular functioning. Such complexity necessitates investigations of disease etiology to be carried out considering multiple aspects of the disease and the use of independent strategies. The established works more emphasized on the structural organization of gene regulatory network while neglecting the internal regulation changes. Methods Applying a strategy different from popularly used co-expression network analysis, this study investigated the transcriptional dysregulations during the transition from normal to disease states. Results 97 genes were predicted as dysregulated genes, which were also associated with clinical outcomes of Alzheimer’s disease. Both the co-expression and differential co-expression analysis suggested these genes to be interconnected as a core network and that their regulations were strengthened during the transition to disease states. Functional studies suggested the dysregulated genes to be associated with aging and synaptic function. Further, we checked the evolutionary conservation of the gene co-expression and found that human and mouse brain might have divergent transcriptional co-regulation even when they had conserved gene expression profiles. Conclusion Overall, our study reveals a profile of transcriptional dysregulation in the genesis of Alzheimer’s disease by forming a core network with altered regulation; the core network is associated with Alzheimer’s diseases by affecting the aging and synaptic functions related genes; the gene regulation in brain may not be conservative between human and mouse.

Abstract licence: CC BY

1. 4.

   Eigengene networks for studying the relationships between co-expression modules · 2007

2. 5.

   WGCNA: an R package for weighted correlation network analysis · 2008

3. 6.

   Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants · 2012

4. 24.

   Evaluation of time profile reconstruction from complex two-color microarray designs · 2008

5. 27.

   Comparison of RNA-Seq and Microarray in Transcriptome Profiling of Activated T Cells · 2014

6. 36.

   Network methods for describing sample relationships in genomic datasets: application to Huntington’s disease · 2012

7. 37.

   Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases · 2014

8. 46.

   Alzheimer’s disease drug-development pipeline: few candidates, frequent failures · 2014

9. 49.

   DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis · 2007

48 more references, whose wording the paper’s licence keeps private.

• The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives · 2022

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.